Literature DB >> 2777803

Antistasin, a leech-derived inhibitor of factor Xa. Kinetic analysis of enzyme inhibition and identification of the reactive site.

C Dunwiddie1, N A Thornberry, H G Bull, M Sardana, P A Friedman, J W Jacobs, E Simpson.   

Abstract

Antistasin is a 119-amino acid protein isolated from the salivary glands of the Mexican leech Haementeria officinalis. The determination of the primary structure of antistasin revealed that the protein is highly disulfide-bonded with a 2-fold internal homology. Antistasin exhibits a potent anticoagulant activity purportedly due to the selective inhibition of Factor Xa (Tuszinsky, G. P., Gasic, T. B., and Gasic, G. J. (1987) J. Biol. chem. 262, 9718-9723). In the present study a detailed kinetic analysis of the inhibitory interaction between antistasin and Factor Xa was performed. In addition, the specificity of antistasin was examined by testing its ability to inhibit a variety of serine proteinases. Utilizing purified antistasin and a tripetidyl p-nitroanilide substrate, antistasin was shown to act as a reversible inhibitor of Factor Xa which exhibits slow-tight binding kinetics. Antistasin reacts stoichiometrically with Factor Xa with inhibition displaying a mixed, primarily competitive type. The inhibition is partial in the presence of Ca2+ and becomes complete in the absence of Ca2+. The estimated dissociation constant for the enzyme-inhibitor complex is between 0.31 and 0.62 nM. After binding to Factor Xa, antistasin is cleaved at a single site to yield a modified inhibitor. Automated gas-phase sequence analysis of the modified inhibitor indicates the arginine residue at position 34 in antistasin occupies the P1 position of the reactive site. These data indicate that the leech has evolved a highly selective and potent inhibitor of coagulation Factor Xa that shares several mechanistic similarities with other serine proteinase inhibitors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2777803

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  18 in total

Review 1.  Advances in thrombolytic therapy.

Authors:  M Verstraete
Journal:  Cardiovasc Drugs Ther       Date:  1992-04       Impact factor: 3.727

Review 2.  The discovery and development of rivaroxaban, an oral, direct factor Xa inhibitor.

Authors:  Elisabeth Perzborn; Susanne Roehrig; Alexander Straub; Dagmar Kubitza; Frank Misselwitz
Journal:  Nat Rev Drug Discov       Date:  2010-12-17       Impact factor: 84.694

Review 3.  New anticoagulants: beyond heparin, low-molecular-weight heparin and warfarin.

Authors:  Shannon M Bates; Jeffrey I Weitz
Journal:  Br J Pharmacol       Date:  2005-04       Impact factor: 8.739

4.  X-ray structure of antistasin at 1.9 A resolution and its modelled complex with blood coagulation factor Xa.

Authors:  R Lapatto; U Krengel; H A Schreuder; A Arkema; B de Boer; K H Kalk; W G Hol; P D Grootenhuis; J W Mulders; R Dijkema; H J Theunissen; B W Dijkstra
Journal:  EMBO J       Date:  1997-09-01       Impact factor: 11.598

Review 5.  New anticoagulant drugs.

Authors:  J I Weitz
Journal:  J Thromb Thrombolysis       Date:  2001-09       Impact factor: 2.300

6.  Tridegin, a new peptidic inhibitor of factor XIIIa, from the blood-sucking leech Haementeria ghilianii.

Authors:  S Finney; L Seale; R T Sawyer; R B Wallis
Journal:  Biochem J       Date:  1997-06-15       Impact factor: 3.857

Review 7.  Novel inhibitors of factor X for use in cardiovascular diseases.

Authors:  F A Spencer; R C Becker
Journal:  Curr Cardiol Rep       Date:  2000-09       Impact factor: 2.931

8.  Anticoagulant repertoire of the hookworm Ancylostoma caninum.

Authors:  P Stassens; P W Bergum; Y Gansemans; L Jespers; Y Laroche; S Huang; S Maki; J Messens; M Lauwereys; M Cappello; P J Hotez; I Lasters; G P Vlasuk
Journal:  Proc Natl Acad Sci U S A       Date:  1996-03-05       Impact factor: 11.205

9.  Isolation from fetal bovine serum of an apolipoprotein-H-like protein which inhibits thymidine incorporation in fetal calf erythroid cells.

Authors:  Q G Li; R Blacher; F Esch; L F Congote
Journal:  Biochem J       Date:  1990-04-01       Impact factor: 3.857

10.  Site-directed mutagenesis of the leech-derived factor Xa inhibitor antistasin. Probing of the reactive site.

Authors:  K J Hofmann; E M Nutt; C T Dunwiddie
Journal:  Biochem J       Date:  1992-11-01       Impact factor: 3.857

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.